New York, January 14, 2014 / Accesswire / Market Buzz Report, which provides live alerts on penny stocks, issues critical stocks analysis for Galena Biopharma Inc (NASDAQ:GALE), Cell Therapeutics Inc (NASDAQ:CTIC), Cliffs Natural Resources Inc (NYSE:CLF), Stratasys, Ltd. (NASDAQ:SSYS)
"Galena Biopharma Inc (NASDAQ:GALE) continues to transform itself before our eyes," Roth Capital's Joseph Pantginis says, praising the company's partnership with Dr. Reddy's. GALE is now "a leading cancer immunotherapy company with NeuVax and FBP vaccines [and] also as a revenue generating company with Abstral for breakthrough cancer pain and likely GALE-401 in 2017," Pantginis adds. Buy rating maintained. Price target hiked to $12 from $11.
Free Urgent Insider Catalyst Report For GALE Available Here: http://marketbuzzreport.com/index.php?code=GALE (Or Copy and paste the URL into your browser)
Cell Therapeutics Inc (NASDAQ:CTIC) rises 3.4% premarket after giving a corporate update. Pacritinib: Top-line data from Phase 3 in myelofibrosis in H2, a second Phase 3 trial is "expected to begin enrollment imminently. "Pixuvri: Company expects to complete enrollment in Phase 3 post-marketing commitment study in relapsed B-cell non-Hodgkin lymphoma in 2015 (endpoint changed to PFS from OS).Tosedostat: Investigator-sponsored trials to resume in Q1. The company says "up-front payment and anticipated near-term milestones related to the Baxter collaboration will potentially allow CTI to reach regulatory submissions for pacritinib without requiring additional equity financing to fund such activities."
Free Urgent Insider Catalyst Report For CTIC Available Here: http://marketbuzzreport.com/index.php?code=CTIC (Or Copy and paste the URL into your browser)
Cliffs Natural Resources Inc (NYSE:CLF) +2% premarket after Deutsche Bank upgrades shares to Buy from Hold with a $27 price target (up from $22) on valuation and strategic outlook given significant management changes and cost reductions. CLF's acquisition of Consolidated Thompson provides an avenue for long-term growth, has re-oriented CLF to the seaborne iron ore market and directs sales to the Asian market, the firm explains. More than half of its consolidated sales volume is priced based on international seaborne benchmarks but U.S. iron ore contracts provide stable price realizations for CLF, the firm says; uneven performance at its coal business remains a concern.
Free Urgent Insider Catalyst Report For CLF Available Here: http://marketbuzzreport.com/index.php?code=CLF (Or Copy and paste the URL into your browser)
Stratasys, Ltd. (NASDAQ:SSYS) -3.8% premarket after guiding FY 2014 earnings below Wall Street estimates, as it warned expenses would rise significantly. Forecasts FY 2014 (Dec.) adjusted EPS of $2.15-$2.25 vs. $2.35 analyst consensus estimate and revenue of $660M-$680M vs. ~$655M consensus. Says higher operating expenses will be driven by investments in sales and marketing programs to drive future market adoption, as well as by higher R&D investments to fund technology innovation and new product development.
Free Urgent Insider Catalyst Report For SSYS Available Here: http://marketbuzzreport.com/index.php?code=SSYS (Or Copy and paste the URL into your browser)
USMarketBuzz.com is an investment community that focuses on MicroCap Securities. USMarketBuzz.com is an authorative authentic Google News Site and Leading Provider of Investment Awareness and Featured Company Profiles. If you would like more information regarding our news coverage solutions, please visit http://www.USMarketBuzz.com/ for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at http://www.USMarketBuzz.com/. Follow us on Facebook: https://www.facebook.com/usmarket.buzz Sign up for our FREE SMS News alerts delivered directly to your mobile phone by texting the word PREPROMO to 27126 (SMS alerts are free, however data rates may apply, check your wireless plan for details.).
Leave a comment...